Intrauterine and postnatal growth failure with normal GH/IGF1 axis and insulin-resistant diabetes in a consanguineous kinship

Jaime Guevara-Aguirre, Marco Guevara-Aguirre, Vivian Hwa, Patricio Prócel, Jeannette Saavedra, Harry Ostrer, Peng Fang, Ron G. Rosenfeld, Sarah Kerns, Arlan L. Rosenbloom

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective: To describe the clinical and biochemical features, and perform molecular analysis for candidate abnormalities in a novel familial syndrome of intrauterine growth retardation (IUGR), failure of an adolescent growth spurt with proportional adult short stature, minimal subluxation of the 5th metacarpal-phalangeal joint, and adult-onset insulin-resistant diabetes unrelated to obesity or other manifestations of metabolic syndrome (MS). Design: Detailed clinical history, auxological, biochemical, radiological, and molecular studies, including DNA analysis and in vitro study of the GH/IGF1 pathway. Materials and methods: Ten affected adults from two generations of five related families were studied in detail, and information obtained about nine other likely affected individuals. Results: Height Z-scores ranged from K7.3 to K3.8. Unaffected parents of the older generation and frequency of confirmed and suspected instances of the syndrome in the two generations studied is consistent with autosomal recessive inheritance. Insulin resistance was uniformly present in seven subjects testedwhowere not taking insulin. Diabetes severity did not correlate with overweight. Subjects did not have other typical manifestations of MS such as substantial hyperlipidemia, osteoporosis, or hypertension. No biochemical abnormality in the GH/IGF1 axis or molecular defect was found. Conclusions:While the association of IUGR and adult MS, including diabetes, has beenwell documented, these subjects did not have typical manifestations of MS. Abnormalities in common components that could result in a combination of IUGR, severe postnatal growth, and insulin resistance have been ruled out. A mutation in an unidentified gene may affect intrauterine and postnatal growth, with insulin resistance directly affected or as a result of this growth phenomenon.

Original languageEnglish (US)
Pages (from-to)521-529
Number of pages9
JournalEuropean Journal of Endocrinology
Volume166
Issue number3
DOIs
StatePublished - Mar 2012

Fingerprint

Insulin
Fetal Growth Retardation
Growth
Insulin Resistance
Metacarpal Bones
Hyperlipidemias
Osteoporosis
Obesity
Joints
Parents
Hypertension
Mutation
DNA
Genes

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Intrauterine and postnatal growth failure with normal GH/IGF1 axis and insulin-resistant diabetes in a consanguineous kinship. / Guevara-Aguirre, Jaime; Guevara-Aguirre, Marco; Hwa, Vivian; Prócel, Patricio; Saavedra, Jeannette; Ostrer, Harry; Fang, Peng; Rosenfeld, Ron G.; Kerns, Sarah; Rosenbloom, Arlan L.

In: European Journal of Endocrinology, Vol. 166, No. 3, 03.2012, p. 521-529.

Research output: Contribution to journalArticle

Guevara-Aguirre, J, Guevara-Aguirre, M, Hwa, V, Prócel, P, Saavedra, J, Ostrer, H, Fang, P, Rosenfeld, RG, Kerns, S & Rosenbloom, AL 2012, 'Intrauterine and postnatal growth failure with normal GH/IGF1 axis and insulin-resistant diabetes in a consanguineous kinship', European Journal of Endocrinology, vol. 166, no. 3, pp. 521-529. https://doi.org/10.1530/EJE-11-0769
Guevara-Aguirre, Jaime ; Guevara-Aguirre, Marco ; Hwa, Vivian ; Prócel, Patricio ; Saavedra, Jeannette ; Ostrer, Harry ; Fang, Peng ; Rosenfeld, Ron G. ; Kerns, Sarah ; Rosenbloom, Arlan L. / Intrauterine and postnatal growth failure with normal GH/IGF1 axis and insulin-resistant diabetes in a consanguineous kinship. In: European Journal of Endocrinology. 2012 ; Vol. 166, No. 3. pp. 521-529.
@article{d17965dcd4d54dd8a4e024737ddd2fea,
title = "Intrauterine and postnatal growth failure with normal GH/IGF1 axis and insulin-resistant diabetes in a consanguineous kinship",
abstract = "Objective: To describe the clinical and biochemical features, and perform molecular analysis for candidate abnormalities in a novel familial syndrome of intrauterine growth retardation (IUGR), failure of an adolescent growth spurt with proportional adult short stature, minimal subluxation of the 5th metacarpal-phalangeal joint, and adult-onset insulin-resistant diabetes unrelated to obesity or other manifestations of metabolic syndrome (MS). Design: Detailed clinical history, auxological, biochemical, radiological, and molecular studies, including DNA analysis and in vitro study of the GH/IGF1 pathway. Materials and methods: Ten affected adults from two generations of five related families were studied in detail, and information obtained about nine other likely affected individuals. Results: Height Z-scores ranged from K7.3 to K3.8. Unaffected parents of the older generation and frequency of confirmed and suspected instances of the syndrome in the two generations studied is consistent with autosomal recessive inheritance. Insulin resistance was uniformly present in seven subjects testedwhowere not taking insulin. Diabetes severity did not correlate with overweight. Subjects did not have other typical manifestations of MS such as substantial hyperlipidemia, osteoporosis, or hypertension. No biochemical abnormality in the GH/IGF1 axis or molecular defect was found. Conclusions:While the association of IUGR and adult MS, including diabetes, has beenwell documented, these subjects did not have typical manifestations of MS. Abnormalities in common components that could result in a combination of IUGR, severe postnatal growth, and insulin resistance have been ruled out. A mutation in an unidentified gene may affect intrauterine and postnatal growth, with insulin resistance directly affected or as a result of this growth phenomenon.",
author = "Jaime Guevara-Aguirre and Marco Guevara-Aguirre and Vivian Hwa and Patricio Pr{\'o}cel and Jeannette Saavedra and Harry Ostrer and Peng Fang and Rosenfeld, {Ron G.} and Sarah Kerns and Rosenbloom, {Arlan L.}",
year = "2012",
month = "3",
doi = "10.1530/EJE-11-0769",
language = "English (US)",
volume = "166",
pages = "521--529",
journal = "European Journal of Endocrinology",
issn = "0804-4643",
publisher = "BioScientifica Ltd.",
number = "3",

}

TY - JOUR

T1 - Intrauterine and postnatal growth failure with normal GH/IGF1 axis and insulin-resistant diabetes in a consanguineous kinship

AU - Guevara-Aguirre, Jaime

AU - Guevara-Aguirre, Marco

AU - Hwa, Vivian

AU - Prócel, Patricio

AU - Saavedra, Jeannette

AU - Ostrer, Harry

AU - Fang, Peng

AU - Rosenfeld, Ron G.

AU - Kerns, Sarah

AU - Rosenbloom, Arlan L.

PY - 2012/3

Y1 - 2012/3

N2 - Objective: To describe the clinical and biochemical features, and perform molecular analysis for candidate abnormalities in a novel familial syndrome of intrauterine growth retardation (IUGR), failure of an adolescent growth spurt with proportional adult short stature, minimal subluxation of the 5th metacarpal-phalangeal joint, and adult-onset insulin-resistant diabetes unrelated to obesity or other manifestations of metabolic syndrome (MS). Design: Detailed clinical history, auxological, biochemical, radiological, and molecular studies, including DNA analysis and in vitro study of the GH/IGF1 pathway. Materials and methods: Ten affected adults from two generations of five related families were studied in detail, and information obtained about nine other likely affected individuals. Results: Height Z-scores ranged from K7.3 to K3.8. Unaffected parents of the older generation and frequency of confirmed and suspected instances of the syndrome in the two generations studied is consistent with autosomal recessive inheritance. Insulin resistance was uniformly present in seven subjects testedwhowere not taking insulin. Diabetes severity did not correlate with overweight. Subjects did not have other typical manifestations of MS such as substantial hyperlipidemia, osteoporosis, or hypertension. No biochemical abnormality in the GH/IGF1 axis or molecular defect was found. Conclusions:While the association of IUGR and adult MS, including diabetes, has beenwell documented, these subjects did not have typical manifestations of MS. Abnormalities in common components that could result in a combination of IUGR, severe postnatal growth, and insulin resistance have been ruled out. A mutation in an unidentified gene may affect intrauterine and postnatal growth, with insulin resistance directly affected or as a result of this growth phenomenon.

AB - Objective: To describe the clinical and biochemical features, and perform molecular analysis for candidate abnormalities in a novel familial syndrome of intrauterine growth retardation (IUGR), failure of an adolescent growth spurt with proportional adult short stature, minimal subluxation of the 5th metacarpal-phalangeal joint, and adult-onset insulin-resistant diabetes unrelated to obesity or other manifestations of metabolic syndrome (MS). Design: Detailed clinical history, auxological, biochemical, radiological, and molecular studies, including DNA analysis and in vitro study of the GH/IGF1 pathway. Materials and methods: Ten affected adults from two generations of five related families were studied in detail, and information obtained about nine other likely affected individuals. Results: Height Z-scores ranged from K7.3 to K3.8. Unaffected parents of the older generation and frequency of confirmed and suspected instances of the syndrome in the two generations studied is consistent with autosomal recessive inheritance. Insulin resistance was uniformly present in seven subjects testedwhowere not taking insulin. Diabetes severity did not correlate with overweight. Subjects did not have other typical manifestations of MS such as substantial hyperlipidemia, osteoporosis, or hypertension. No biochemical abnormality in the GH/IGF1 axis or molecular defect was found. Conclusions:While the association of IUGR and adult MS, including diabetes, has beenwell documented, these subjects did not have typical manifestations of MS. Abnormalities in common components that could result in a combination of IUGR, severe postnatal growth, and insulin resistance have been ruled out. A mutation in an unidentified gene may affect intrauterine and postnatal growth, with insulin resistance directly affected or as a result of this growth phenomenon.

UR - http://www.scopus.com/inward/record.url?scp=84857941135&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857941135&partnerID=8YFLogxK

U2 - 10.1530/EJE-11-0769

DO - 10.1530/EJE-11-0769

M3 - Article

VL - 166

SP - 521

EP - 529

JO - European Journal of Endocrinology

JF - European Journal of Endocrinology

SN - 0804-4643

IS - 3

ER -